Regulation of paracellular absorption of cimetidine and 5- aminosalicylate in rat intestine

Pharmaceutical Research

Volumn 16, Issue 11, 1999, Pages 1781-1785

  Zhou, Simon Yuji ^a   Piyapolrungroj, Nusara ^b   Pao, Li Heng ^c   Li, Cheng ^d   Liu, Guangyu ^e   Zimmermann, Ellen ^f   Fleisher, David ^e  

^a PFIZER INC   (United States)

^b SILPAKORN UNIVERSITY   (Thailand)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d MERCK RESEARCH LABORATORIES   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

5 aminosalicylate; Cimetidine; Intestinal absorption; Intestinal metabolism; Paracellular transport

Indexed keywords

CIMETIDINE; MESALAZINE; THIAMAZOLE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DRUG ABSORPTION; DRUG METABOLISM; HYDROPHILICITY; INTRACELLULAR TRANSPORT; JEJUNUM DISEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEADY STATE;

ANESTHESIA; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; BIOLOGICAL TRANSPORT, ACTIVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIMETIDINE; DRUG INTERACTIONS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; JEJUNUM; MALE; MESALAMINE; METHIMAZOLE; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032706586     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018974519984     Document Type: Article

References (30)

1. 1. K. R. Spring. Routes and mechanism of fluid transport by epithelia. Ann. Rev. Physiol. 60:105-119 (1908).
2. 2. K. H. Soergel. Showdown at the tight junction. Gastroenterology 105:1247-1250 (1993).
3. 3. J. R. Turner, B. K. Rill, S. L. Carlson, D. C Arnes, R. Kerner, R. J. Mrsny, and J. L. Madara. Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation. Am. J. Physiol. 273:C1378-1385 (1997).
4. 4. L. L. Mitic and J. M. Anderson. Molecular architecture of tight junctions. Ann. Rev. Physiol. 60:121-42 (1998).
5. 5. V. Pade and S. Stavchansky. Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the Caco-2 cell culture model. Pharm. Res. 14:1210-1215 (1997).
6. 6. H. Lennernas. Does fluid flow across the intestinal mucosa affect quantitative oral drug absorption? Is it time for a reevaluation? Pharm. Res. 12:1573-1582 (1995).
7. 7. J. M. Mullin, C. W. Marano, K. V. Laughlin, M. Nuciglio, B. R. Stevenson, and P. Soler. Different size limitations for increased transepithelial paracellular solute flux across phorbol ester and tumor necrosis factor-treated epithelial cell sheets. J. Cell. Physiol. 171:226-33 (1997).
8. 8. G. M. Pauletti, F. W. Okumu, and R.T. Borchardt. Effect of size and charge on the passive diffusion of peptides across Caco-2 cell monolayers via the paracellular pathway. Pharm. Res. 14:164-168 (1997).
9. 9. H. Ghandehari, P. L. Smith, H. Ellens, P. Y. Yeh, and J. Kopecek. Size-dependent permeability of hydrophilic probes across rabbit colonic epithelium. J. Pharmacol. Exp. Ther. 280:747-753 (1997).
10. 10. R. M. van Elburg, J. J. Uil, F. T. Kokke, A. M. Mulder, W. G. van de Broek, C. J. Mulder and H. S. Heymans. Repeatability of the sugar-absorption test, using lactulose and mannitol, for measuring intestinal permeability for sugars. J. Ped. Gastroent. Nutr. 20:184-888 (1995).
11. 11. L. Lazorova, J. Grasjo, P. Artursson, M. Bergstrom, F. Wu, E. Petterman-Bergstrom, M. Ogren, and B. Langstrom. Quantification and imaging of mannitol transport through Caco-2 cell monolayers using a positron-emitting tracer. Pharm. Res. 15:1141-1444 (1998).
12. 12. R. M. Schwanz, J. K. Furne, and M. D. Levitt. Paracellular intestinal transport of six-carbon sugars is negligible in the rat. Gastroenterology 109:1206-1213 (1995).
13. 13. J. L. Madara. Regulation of the movement of solutes across tight junctions. Ann. Rev. Physiol. 60:143-159 (1998).
14. 14. S. Y. Zhou, D. Fleisher, L. H. Pao, C. Li, B. Winward, and E. M. Zimmermann. Intestinal metabolism and elimination of 5-aminosalicylic acid. Drug Metab. Dispos 27:479-485 (1999).
15. 2-antagonists. Biochem. Pharmacol. 48:229-231 (1994).
16. 16. X. Lu, C. Li, and D. Fleisher. Cimetidine sulfoxidation in small intestinal microsomes. Drug Metab. Dispos. 26:940-942 (1998).
17. 17. N. Piyapolrungroj, Y. S. Zhou, C. Li, G. Liu, E. Zimmermann, and D. Fleisher. Cimetidine intestinal absorption and elimination in rat small intestine. revision submitted to Drug Metab. Dispos. (1999).
18. 18 N. Piyapolrungroj, C. Li, R. L. Pisoni, and D. Fleisher. Cimetidine transport in brush border membrane vesicles from rat small intestine. J. Pharmacol. Exp. Ther. 289:346-353 (1999).
19. 19. M. Perez, A. Barber, and F. Ponz: Modulation of intestinal paracellular permeability by intracellular mediators and cytoskeleton. Can. J. Physiol. Pharmacol. 75:287-92 (1997).
20. 2-antagonists. Pharm. Res. 15:53-57 (1998).
21. 21. P. V. Pedersen and R. Miller: Pharmacokinetics and bioavailability of cimetidine in humans. J. Pharm. Sci. 69:394-348 (1980).
22. 22. A. Grahnen, C. von Bahr, B. Lindstrom, and A. Rosen. Bioavailability and pharmacokinetics of cimetidine. Eur. J. Clin. Pharmacol. 16:335-340 (1979).
23. 23. A. Somogyi and R. Gugler: Clinical pharmacokinetics of cimetidine. Clin. Pharmacokin. 8:463-495 (1983).
24. 24. S. S. Walkenstein, J. W. Dubb, W. C. Randolph, W. J. Westlake, R. M. Stote, and A. P. Intoccia. Bioavailability of cimetidine in man. Gastroenterology 74:360-365 (1978).
25. 25. A. Somogyi and M. Muirhead. Pharmacokinetic interactions of cimetidine. Clin. Pharmacokin. 12:321-366 (1987).
26. 26. F. P. Guengerich. Role of cytochrome P450 enzymes in drug-drug interactions. Adv. Pharmacol. 43:7-35 (1997).
27. 27. L. B. Slusher and E. S. Vesell. Cimetidine-induced reduction in gastrointestinal absorption of antipyrine and rate constants for formation of its metabolites. Clin. Pharmacol. Ther. 35:568-75 (1984).
28. 28. M. R. Muirhead, A. A. Somogyi, P. E. Rolan, and F. Bochner. Effect of cimetidine on renal and hepatic drug elimination: studies with triamterene. Clin. Pharmacol. Ther. 40:400-407 (1986).
29. 29. G. C. Sturniolo, M. C. Montino, L. Rossetto, A. Martin, R. D'Inca, A. D'Odorico, and R. Naccarato. Inhibition of gastric acid secretion reduces zinc absorption in man. J. Amer. Coll. Nutr. 10:372-375 (1991).
30. 30. M. Muirhead, F. Bochner, and A. Somogyi: Pharmacokinetic drug interactions between triamterene and ranitidine in humans: alterations in renal and hepatic clearances and gastrointestinal absorption. J. Pharmacol. Exp. Ther. 244:734-739 (1988).